StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb Co. (BMY) PT Raised to $53 at BofA/Merrill Lynch
January 25, 2019 6:07 AM
BofA/Merrill Lynch analyst Jason Gerberry ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
BMO Capital Reiterates Outperform on Bristol-Myers Squibb (BMY)
January 25, 2019 8:45 AM